Wednesday, March 11, 2026
Home Authors Posts by Ogkologos

Ogkologos

4164 POSTS 0 COMMENTS

ESMO Asia Congress 2024, Singapore, 6-8 December

Ogkologos -
0

EMA Recommends Granting a Conditional Marketing Authorisation for Repotrectinib

Ogkologos -
0

FDA Grants Accelerated Approval to Asciminib for Newly Diagnosed Chronic Myeloid...

Ogkologos -
0

Adding Pembrolizumab to Chemotherapy Results in Improved PFS and OS in...

Ogkologos -
0

Neoadjuvant Nivolumab/Relatlimab Induces High Rates of Pathologic Responses in Patients with...

Ogkologos -
0

Trial Results Support SBRT as a Standard Option for Some Prostate...

Ogkologos -
0

Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage...

Ogkologos -
0

FDA Approves Inavolisib with Palbociclib and Fulvestrant for Endocrine-Resistant, PIK3CA-mutated, HR-positive,...

Ogkologos -
0

EMA Recommends Extension of Indications for Tislelizumab to First-Line Treatment of...

Ogkologos -
0

Perioperative Durvalumab Plus Neoadjuvant Chemotherapy Improves EFS and OS in Cisplatin-Eligible...

Ogkologos -
0
1...404142...417Page 41 of 417

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com